Skip to content
Palifosfamide
Palifosfamide is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
363 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SarcomaD0125091544241884
Large b-cell lymphoma diffuseD016403C83.3111731—28
Non-hodgkin lymphomaD008228C85.941621121
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.02494—17
Germ cell and embryonal neoplasmsD00937311221116
Burkitt lymphomaD002051C83.715—2—7
Large-cell lymphoma anaplasticD017728C84.634—1—6
T-cell lymphoma peripheralD016411C84.931—1—4
Enteropathy-associated t-cell lymphomaD058527C86.21——1—2
Mediastinal neoplasmsD008479C38.3——11—2
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LymphomaD008223C85.99367—349
NeoplasmsD009369C801783—124
Ovarian neoplasmsD010051EFO_0003893C567135——19
OsteosarcomaD012516594—318
LeukemiaD007938C952106—118
Hodgkin diseaseD006689C818122——16
NeuroblastomaD009447EFO_0000621363—112
Central nervous system neoplasmsD016543482——11
Ewing sarcomaD012512EFO_0000173131—49
Lung neoplasmsD008175C34.90145——9
Show 34 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C5018———8
B-cell lymphomaD01639333———5
Urinary bladder neoplasmsD001749C6715———5
Mantle-cell lymphomaD020522C83.133———4
Follicular lymphomaD008224C8224———4
Testicular neoplasmsD013736C6212———3
Embryonal carcinomaD018236—2———2
Brain neoplasmsD001932EFO_0003833C71—1——12
Liver neoplasmsD008113EFO_1001513C22.021———2
T-cell lymphomaD01639921———2
Show 30 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Primitive neuroectodermal tumorsD0182421———23
RetinoblastomaD0121751———12
Mycosis fungoidesD009182C84.01————1
ThymomaD0139451————1
T-cell leukemiaD0154581————1
Neoplasm metastasisD009362EFO_00097081————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
VomitingD014839HP_0002013R11.1————22
Drug-related side effects and adverse reactionsD064420T88.7————11
NauseaD009325HP_0002018R11.0————11
MedulloblastomaD008527————11
HepatoblastomaD018197C22.2————11
Retinal neoplasmsD019572C69.2————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePALIFOSFAMIDE
INNpalifosfamide
Description
Isophosphamide mustard is a phosphorodiamide.
Classification
Small molecule
Drug classphosphoro-derivatives; isophosphoramide mustard derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
O=P(O)(NCCCl)NCCCl
Identifiers
PDB—
CAS-ID31645-39-3
RxCUI—
ChEMBL IDCHEMBL889
ChEBI ID80566
PubChem CID100427
DrugBank—
UNII ID6A4U6NN813 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 117 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details